Genelux appoints Eric Groen as general counsel, corporate secretary, CCO

Genelux Corporation (GNLX) announced the appointment of Eric Groen as General Counsel, Corporate Secretary, Chief Compliance Officer and Head of Business Development. Most recently, Mr. Groen served as General Counsel of Rani Therapeutics (RANI). In connection with his appointment, Mr. Groen was granted an inducement award of a stock option to purchase 270,000 shares of common stock under Genelux’s 2023 Inducement Plan in accordance with Nasdaq Listing Rule 5635(c)(4), at an exercise price of $2.83 per share. The inducement award will vest over four years, with 25% of the underlying shares vesting on the one-year anniversary of the vesting commencement date and the balance of the underlying shares vesting monthly thereafter over 36 months, subject to Mr. Groen’s continued service relationship with the company through the applicable vesting dates.